(888) 552-6760 SCHEDULE AN APPOINTMENT

Edward Boas,

Interventional Radiologist

Biography photo
Location
Duarte Comprehensive Cancer Center
1500 East Duarte Road
Duarte, CA 91010
Education
Medical school:
Board Certifications
  • Interventional radiology
  • Diagnostic radiology
Degrees
  • 2008, M.D., Ph.D., Biochemistry, Stanford University
Professional Experience
  • 2021-present, Associate Professor, Department of Diagnostic Radiology, City of Hope, Duarte, California
Fellowship
  • 2013-2014, Interventional radiology, Hospital of the University of Pennsylvania
Residency
  • 2009-2013, Radiology, Stanford Hospital
Internship
  • 2008-2009, General surgery, Stanford Hospital
Academic Appointments
  • Associate Professor, Department of Diagnostic Radiology
About Me

As an interventional radiologist, Edward Boas, M.D., Ph.D., performs minimally invasive cancer treatment procedures using needles and catheters, providing a less invasive alternative to surgery for many patients. This involves guiding a needle or a catheter toward a tumor using computed tomography, ultrasound or X-rays, then burning or freezing the tumor (ablation), blocking its blood supply (embolization) or implanting microscopic radioactive particles to treat it (radioembolization). These procedures can be used to treat cancer in the lung, liver and kidney. He also reopens blood vessels that are blocked or narrowed by a blood clot or a tumor, using minimally invasive techniques that are performed through a catheter. 
 
Dr. Boas has performed thousands of image-guided procedures and uses a multidisciplinary clinical approach, which involves coordinating care with surgeons, oncologists and other specialists to decide the best treatment strategy for each patient. Dr. Boas teaches other doctors how to perform these procedures at national meetings, and he is a reviewer for several medical journals. 
 
Dr Boas is currently running a phase II clinical trial of lung chemoembolization, which is a new treatment option for lung cancer that is not responding to systemic therapy. Rather than injecting chemotherapy into a vein, the chemotherapy is delivered directly into the tumor, which potentially reduces side effects and improves efficacy.  City of Hope is currently the only site in the US offering this localized chemotherapy treatment for non-small cell lung cancer. 
 
Dr Boas' also runs the Interventional Oncology Bioengineering Laboratory, which develops new minimally invasive therapies for liver, pancreatic, and lung cancer.  The lab is focused on local immunotherapy / in situ cancer vaccination, which is a new method for training the immune system to recognize and destroy cancer cells
 

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.